June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Human neural stem cells phagocytose photoreceptor outer segments and preserve synaptic contacts in the degenerating rodent retina
Author Affiliations & Notes
  • Alexandra Capela
    Neural Group, StemCells Inc, Newark, CA
  • Laura Fernandez-Sanchez
    Physiology, Genetics and Microbiology, University of Alicante, Alicante, Spain
  • Trevor McGill
    Casey Eye Institute, Oregon Health and Science University, Portland, OR
  • Bin Lu
    Regenerative Medicine Institute, Cedars Sinai Medical Center, Los Angeles, CA
  • Raymond Lund
    Moran Eye Center, University of Utah, Salt Lake City, UT
  • Stephen Huhn
    Neural Group, StemCells Inc, Newark, CA
  • Nicolas Cuenca
    Physiology, Genetics and Microbiology, University of Alicante, Alicante, Spain
  • Footnotes
    Commercial Relationships Alexandra Capela, StemCells Inc (E); Laura Fernandez-Sanchez, None; Trevor McGill, StemCells, Inc. (C), Pfizer (F), AGTC (F); Bin Lu, None; Raymond Lund, None; Stephen Huhn, StemCells Inc (E); Nicolas Cuenca, Universidad de Alicante (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2210. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Alexandra Capela, Laura Fernandez-Sanchez, Trevor McGill, Bin Lu, Raymond Lund, Stephen Huhn, Nicolas Cuenca; Human neural stem cells phagocytose photoreceptor outer segments and preserve synaptic contacts in the degenerating rodent retina. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2210.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Previous studies in our lab have shown that transplantation of human central nervous system stem cells (HuCNS-SC®) into the subretinal space of RCS rats preserves photoreceptors and visual function. To explore the possible mechanism(s) of action underlying this neuroprotective effect, we performed a detailed morphological and ultrastructure analysis of HuCNS-SC transplanted retinas using Electron Microscopy (EM)

Methods: HuCNS-SC were transplanted into the subretinal space of immunosuppressed RCS rats at P21. Histological examination of the transplanted retinas was performed by light and electron microscopy of whole mount preparations at P60 and P90. HuCNS-SC cells were identified by pre-embedding immunohistochemistry with a human specific antibody STEM121. Areas of the retina with HuCNS-SC graft (treated regions) were compared to control sections distal from the transplant site (untreated regions).

Results: Semi-thin sections were first examined by light microscopy. In the treated regions, photoreceptor nuclei, as well as inner and outer segments were readily identified. In the untreated regions; few if any photoreceptor nuclei were identified, rod outer and inner segments were missing and a debris zone formed contiguous to the photoreceptor layer. These observations are in agreement with published data. Detailed ultrastructure analysis by EM revealed the presence of phagosomes and vesicles exhibiting the lamellar structure of outer segments within the cytosol of human cells, indicating that HuCNS-SC have phagocytic capacity in vivo, a function typically carried out by healthy retinal pigment epithelium (RPE). Finally, the outer plexiform layer (OPL) thickness appeared increased in treated regions and exhibited a remarkable preservation of the photoreceptor-bipolar-horizontal cell synaptic contacts, an observation not previously reported.

Conclusions: This study reveals for the first time that phagocytosis of photoreceptor outer segments by HuCNS-SC is a mechanism of retinal neuroprotection in the RCS rat. In addition to photoreceptor rescue, preservation of synaptic connections in the retina is also achieved through HuCNS-SC transplantation and likely supports maintenance of visual function. Clinical testing of HuCNS-SC in age-related macular degeneration is underway in a Phase I/II FDA-approved trial.

Keywords: 721 stem cells • 741 transplantation • 656 protective mechanisms  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×